SBI Dividend Yield Fund
SBI Mutual Fund · Dividend Yield · Direct Idcw · AMFI 151475 · ISIN INF200KA15W0
NAV₹16.595320 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio1.14%₹7,794 Cr
Growth Score—
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | — | — | — | — | — | — | — | — | — | — |
| NIFTY 500 TRI | +9.37% | +2.62% | +7.46% | +1.91% | +1.50% | +12.11% | +10.50% | +14.75% | — | — |
| Category middle | +7.44% | +1.61% | +6.25% | +1.36% | +1.16% | +11.91% | +13.31% | +17.30% | +15.00% | — |
Risk (36 months)
| Volatility | — |
| Sharpe | — |
| Sortino | — |
| Beta | — |
| Alpha | — |
| Deepest fall | — |
| 1-year periods with a loss | — |
| 5Y SIP XIRR | — |
Top holdings (31 Oct 2026)
| ICICI Bank Ltd. | 5.20% |
| TREPS | 4.19% |
| Kotak Mahindra Bank Ltd. | 3.91% |
| Larsen & Toubro Ltd. | 3.68% |
| Acme Solar Holdings Ltd. | 3.46% |
| Life Insurance Corporation of India | 3.37% |
| Interglobe Aviation Ltd. | 2.63% |
| Embassy Office Parks Reit | 2.61% |
| Tech Mahindra Ltd. | 2.50% |
| Nexus Select Trust | 2.46% |
| Corona Remedies Ltd. | 2.37% |
| Aurobindo Pharma Ltd. | 2.33% |
Sectors
| Pharmaceuticals & Biotechnology | 12.0% |
| Banks | 9.1% |
| Realty | 7.8% |
| Automobiles | 7.0% |
| Power | 5.8% |
| Transport Services | 5.0% |
| Healthcare Services | 4.7% |
| Auto Components | 4.5% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.